UBS Maintains Neutral on Surgery Partners, Raises Price Target to $12

UBS maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $7.5 to $12.

Benzinga · 11/12/2019 12:40

UBS maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $7.5 to $12.